Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

Clinical trial NCT05531149 · TERMINATED

Trial details

NCT number: NCT05531149
Sponsor: Biotest
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Respiratory Infection Pneumonia Community-acquired Pneumonia Acute Respiratory Distress Syndrome COVID-19 Viral Pneumonia Bacterial Pneumonia Fungal Pneumonia

Start date: 2022-12-22
Primary completion: 2025-05-05
Enrollment: 107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.